Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Gregory B. Kruse, Michele H. Potashman, Spyros Stavrakas & Bruce J. Wong. (2014) Administration costs of intravenous chemotherapy in treating peripheral T-cell lymphoma. Journal of Medical Economics 17:7, pages 446-458.
Read now
Read now
Pier Luigi Zinzani. (2013) Peripheral T-cell lymphomas: in “real life” experience are we really improving?. Leukemia & Lymphoma 54:11, pages 2337-2338.
Read now
Read now
Articles from other publishers (25)
Mathew Angelos, Hatcher Ballard & Stefan Barta. (2022) Advances and Personalized Approaches in the Frontline Treatment of T-Cell Lymphomas. Journal of Personalized Medicine 12:2, pages 267.
Crossref
Crossref
Galal H. Elgemeie & Reham A. Mohamed-Ezzat. 2022. New Strategies Targeting Cancer Metabolism. New Strategies Targeting Cancer Metabolism
35
67
.
Sh. Bayat, M. Zeinoddini, A. Azizi & M. A. Nasiri Khalili. (2019) Co-Solvents Effects on the Stability of Recombinant Immunotoxin Denileukin Diftitox: Structure and Function Assessment. Iranian Journal of Science and Technology, Transactions A: Science 43:5, pages 2091-2097.
Crossref
Crossref
David A Pride & Alyssa R Summers. (2018) The emergence of specific HDAC inhibitors and their clinical efficacy in the treatment of hematologic malignancies and breast cancer. International Journal of Molecular Biology 3:5.
Crossref
Crossref
Ling Li, Wenjing Duan, Lei Zhang, Xin Li, Xiaorui Fu, Xinhua Wang, Jingjing Wu, Zhenchang Sun, Xudong Zhang, Yu Chang, Feifei Nan, Jiaqin Yan, Zhaoming Li, Ken H. Young & Mingzhi Zhang. (2017) The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers. British Journal of Haematology 178:5, pages 772-780.
Crossref
Crossref
Ciara Conduit, Rosemary Harrup, Scott Ragg & Anna Johnston. (2017) An audit of patients with mature T‐cell non‐Hodgkin lymphoma by transplant status in Tasmania. Internal Medicine Journal 47:4, pages 464-466.
Crossref
Crossref
Bhatia Ravi Kant, Bhatia Shashi Kant, Bhalla Tek Chand & Bhatt Arvind Kumar. 2017. Microbial Applications Vol.2. Microbial Applications Vol.2
169
184
.
Mariko Yabe, L. Jeffrey Medeiros, Guilin Tang, Sa A. Wang, Sairah Ahmed, Yago Nieto, Shimin Hu, Govind Bhagat, Yasuhiro Oki, Keyur P. Patel, Mark Routbort, Rajyalakshmi Luthra, Michelle A. Fanale, Carlos E. Bueso-Ramos, Jeffrey L. Jorgensen, Francisco Vega, Weina Chen, Daniela Hoehn, Sergej Konoplev, Denai R. Milton, Ignacio Wistuba, Shaoying Li, M. James You, Ken H. Young & Roberto N. Miranda. (2016) Prognostic Factors of Hepatosplenic T-cell Lymphoma. American Journal of Surgical Pathology 40:5, pages 676-688.
Crossref
Crossref
Rosaria BenedettiMariarosaria ConteLucia Altucci. (2015) Targeting Histone Deacetylases in Diseases: Where Are We?. Antioxidants & Redox Signaling 23:1, pages 99-126.
Crossref
Crossref
Wenji Yan & Mingzhou Guo. 2015. Cancer Epigenetics. Cancer Epigenetics
405
424
.
Koppany Visnyei, Michael L. Grossbard & Ilan Shapira. (2013) Hepatosplenic γδ T-cell Lymphoma: An Overview. Clinical Lymphoma Myeloma and Leukemia 13:4, pages 360-369.
Crossref
Crossref
Antonino Grassadonia, Pasquale Cioffi, Felice Simiele, Laura Iezzi, Marinella Zilli & Clara Natoli. (2013) Role of Hydroxamate-Based Histone Deacetylase Inhibitors (Hb-HDACIs) in the Treatment of Solid Malignancies. Cancers 5:4, pages 919-942.
Crossref
Crossref
Kankana Bardhan & Kebin Liu. (2013) Epigenetics and Colorectal Cancer Pathogenesis. Cancers 5:4, pages 676-713.
Crossref
Crossref
Pamela D. Martin & David J. Argyle. 2013. Advances in Veterinary Dermatology. Advances in Veterinary Dermatology
187
196
.
Pamela D. Martin & David J. Argyle. (2013) Advances in the management of skin cancer. Veterinary Dermatology 24:1, pages 173-e38.
Crossref
Crossref
Ling-Zhi Wang, Jacqueline Ramírez, Winnie Yeo, Mei-Yi Michelle Chan, Win-Lwin Thuya, Jie-Ying Amelia Lau, Seow-Ching Wan, Andrea Li-Ann Wong, Ying-Kiat Zee, Robert Lim, Soo-Chin Lee, Paul C. Ho, How-Sung Lee, Anthony Chan, Sherry Ansher, Mark J. Ratain & Boon-Cher Goh. (2013) Glucuronidation by UGT1A1 Is the Dominant Pathway of the Metabolic Disposition of Belinostat in Liver Cancer Patients. PLoS ONE 8:1, pages e54522.
Crossref
Crossref
Faramarz Naeim, P. Nagesh Rao, Sophie X. Song & Wayne W. Grody. 2013. Atlas of Hematopathology. Atlas of Hematopathology
587
591
.
Manish K. Gupta, Gagandip Singh & Swati Gupta. 2013. Hydroxamic Acids. Hydroxamic Acids
173
204
.
Claudia Kapser, Tanja Maier & Michael J. Flaig. 2013. Fortschritte der praktischen Dermatologie und Venerologie 2012. Fortschritte der praktischen Dermatologie und Venerologie 2012
673
675
.
Michael Youngjun Choi & Mary Jo Lechowicz. (2012) Management of the Cutaneous Peripheral T-Cell Lymphomas. The Cancer Journal 18:5, pages 439-444.
Crossref
Crossref
Bettina Bisig, Philippe Gaulard & Laurence de Leval. (2012) New biomarkers in T-cell lymphomas. Best Practice & Research Clinical Haematology 25:1, pages 13-28.
Crossref
Crossref
Nessa Carey. (2012) Epigenetics—an emerging and highly promising source of new drug targets. MedChemComm 3:2, pages 162-166.
Crossref
Crossref
Robert W. Robey, Arup R. Chakraborty, Agnes Basseville, Victoria Luchenko, Julian Bahr, Zhirong Zhan & Susan E. Bates. (2011) Histone Deacetylase Inhibitors: Emerging Mechanisms of Resistance. Molecular Pharmaceutics 8:6, pages 2021-2031.
Crossref
Crossref
Rosalyn A. Juergens, John Wrangle, Frank P. Vendetti, Sara C. Murphy, Ming Zhao, Barbara Coleman, Rosa Sebree, Kristen Rodgers, Craig M. Hooker, Noreli Franco, Beverly Lee, Salina Tsai, Igor Espinoza Delgado, Michelle A. Rudek, Steven A. Belinsky, James G. Herman, Stephen B. Baylin, Malcolm V. Brock & Charles M. Rudin. (2011) Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non–Small Cell Lung Cancer. Cancer Discovery 1:7, pages 598-607.
Crossref
Crossref
Amélie Lansiaux. (2011) Les antimétabolites. Bulletin du Cancer 98:11, pages 1263-1274.
Crossref
Crossref